| Home > Authorities > Institutes > Record #182051 |
MU08
Translationale Onkologie mit dem Schwerpunkt Reverse Translation Also known as:- DKTK MU Sos| ID | I:(DE-He78)MU08-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
AURORA A interacts with DICER and SETD2 to promote S-phase progression.
EMBO reports 27(15), 4493-4523 (2026) [10.1038/s44319-026-00850-0]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.
Molecular oncology nn, nn (2026) [10.1002/1878-0261.70264]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
A disease model resource reveals core principles of tissue-specific cancer evolution.
Nature 653, 265–276 (2026) [10.1038/s41586-026-10187-2]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies
JTO clinical and research reports 7(4), 100944 (2026) [10.1016/j.jtocrr.2025.100944]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |